Medical Compression Systems Selects Mr. Gerry Feldman As New CEO
CONCORD, Massachusetts, July 19, 2016 /PRNewswire/ -- Medical Compression Systems (MCS) (TASE: MDCL), manufacturer of ActiveCare® smart compression products, announced today that its board of directors has appointed Mr. Gerry Feldman as the company's Chief Executive Officer. Mr. Feldman, who currently serves as MCS's Vice Chairman of its Board of Directors, brings broad industry leadership experience in manufacturing and marketing of medical devices. He has served on the board of numerous Israeli medical device companies and has served as the President of Oridion Medical as well as holding other senior managerial roles at Covidien, Thermo Electron, International Technidyne Corporation and JFK Medical Center.
About ActiveCare®
ActiveCare® is a brand of MCS, a leader in innovative, non-invasive, smart compression treatments that enhance arterial, venous and lymphatic circulation and create new clinical and economic value more safely and effectively than other available alternatives. The company is the first and only one to offer the healthcare market a new class of therapy in combination with MCS's patented Synchronized Flow Technology (ActiveCare® + S.F.T.) device, which can reduce the risk of bleeding complications, thus improving the standard of health care. ActiveCare® fully meets the American College of Chest Physicians' Evidence-Based Clinical Practice Guidelines (ACCP 2012) to prevent DVT after total joint replacement for the duration of treatment, from hospital to home.
About MCS Medical Compression Systems
Founded in 1997, MCS Medical Compression Systems (Ltd.) is an Israeli public company traded on the Tel Aviv Stock Exchange (TASE: MDCL). MCS Inc., the company's subsidiary, is located in the USA. For more information, please visit http://www.activecare.mcsmed.com.
Media Contact:
Mrs. Tlalit Bussi Tel Tzur - VP Marketing
MCS - Medical Compression System
Tlalit@mcsmed.com
About ActiveCare®
ActiveCare® is a brand of MCS, a leader in innovative, non-invasive, smart compression treatments that enhance arterial, venous and lymphatic circulation and create new clinical and economic value more safely and effectively than other available alternatives. The company is the first and only one to offer the healthcare market a new class of therapy in combination with MCS's patented Synchronized Flow Technology (ActiveCare® + S.F.T.) device, which can reduce the risk of bleeding complications, thus improving the standard of health care. ActiveCare® fully meets the American College of Chest Physicians' Evidence-Based Clinical Practice Guidelines (ACCP 2012) to prevent DVT after total joint replacement for the duration of treatment, from hospital to home.
About MCS Medical Compression Systems
Founded in 1997, MCS Medical Compression Systems (Ltd.) is an Israeli public company traded on the Tel Aviv Stock Exchange (TASE: MDCL). MCS Inc., the company's subsidiary, is located in the USA. For more information, please visit http://www.activecare.mcsmed.com.
Media Contact:
Mrs. Tlalit Bussi Tel Tzur - VP Marketing
MCS - Medical Compression System
Tlalit@mcsmed.com